China Universal Asset Management Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,503 shares of HRMY stock, worth $407,781. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,503
Previous 12,093
4.88%
Holding current value
$407,781
Previous $416,000
8.41%
% of portfolio
0.04%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding HRMY
# of Institutions
283Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$56 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.7 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...